06-30-1962
N39.0
99309
Monitor Ciprofloxacin
Follow the patient with a urinary tract infection on antibiotic therapy. The patient was assessed at the bedside AAOX3. The patient denies chest pain, palpitations, SOB, chills, confusion, headache, blurry vision, diaphoresis, and pain in urination. Continue the current antibiotic treatment; the last dose will be today, 03/21/25. The patient is tolerating it well. No adverse or allergic reactions were reported. According to the nurse, the patient is compliant with the treatment, and there have been no overnight events. Continue to monitor intake and output. The patient was educated about daily showering, hand washing, and oral care.
No known allergies
Ciprofloxacin HCl tablet; 500 mg; amt: 500 mg; oral Special Instructions: Dx. UTI. Twice A Day. Begin: 03/19/2025 - 03/28/2025 Ending: 03/28/2025
N39.0 Urinary tract infection, site not specified
Ciprofloxacin HCl tablet; 500 mg; amt: 500 mg; oral Special Instructions: Dx. UTI. Twice A Day. Begin: 03/19/2025 - 03/28/2025 Ending: 03/28/2025
It is recommended to continue monitoring the patient’s progress with the urinary tract infection (UTI) while they are completing their antibiotic therapy. The patient remains alert and oriented (AAOX3) and has denied any concerning symptoms such as chest pain, palpitations, shortness of breath, chills, confusion, headache, blurry vision, diaphoresis, or pain with urination. The patient has tolerated the antibiotic treatment well, with no adverse or allergic reactions reported, and is compliant with the prescribed regimen. The last dose of antibiotics will be administered today, 03/21/25, and the patient should complete the full course of treatment. It is important to continue monitoring the patient's intake and output, ensuring proper hydration. Additionally, reinforce the importance of maintaining good hygiene practices, including daily showering, regular hand washing, and oral care, to help prevent further infections. Follow-up assessments Should be scheduled to evaluate the patient’s response to treatment and ensure resolution of the infection.
99309
YES
24
1
Powered by © https://quintadb.com